GlassScriptPhysician profile
James T Luu
NPI 1104915198
$14,419.41
in general payments reported to CMS, 2019-2025
35 companies · $2,491 in 2025
The $2,491 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,613 · 2020: $1,592 · 2021: $3,029 · 2022: $2,269 · 2023: $1,031 · 2024: $1,395 · 2025: $2,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,917.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,531.22 | 2019-2025 | Breztri, Farxiga |
| Abbvie INC. | $2,158.43 | 2021-2025 | |
| Amgen INC. | $1,323.98 | 2019-2022 | |
| Novo Nordisk INC | $1,304.57 | 2019-2025 | Wegovy |
| Scilex Pharmaceuticals INC. | $1,133.14 | 2019-2024 | Ztlido |
| Lilly USA, LLC | $845.40 | 2019-2025 | Mounjaro, Zepbound |
| Allergan, INC. | $658.72 | 2019-2020 | |
| Pfizer INC. | $628.16 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $458.62 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $356.06 | 2021 | |
| Amarin Pharma, INC. | $301.53 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $277.69 | 2025 | Purified Cortrophin Gel |
| Bausch Health US, LLC | $271.21 | 2019-2020 | |
| Dexcom, INC. | $257.69 | 2024-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $206.79 | 2020-2025 | Capvaxive, M-M-R II, Gardasil 9 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $194.45 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.94 | 2022-2025 | |
| Boston Scientific Corporation | $150.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $143.61 | 2022 | |
| Genentech USA, INC. | $143.14 | 2022 | |
| Edwards Lifesciences Corporation | $135.64 | 2022 | |
| Viatris Specialty LLC | $125.00 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2020 | |
| Urovant Sciences INC | $116.26 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $104.41 | 2024 | Siliq |
| Biogen, INC. | $58.69 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $57.38 | 2025 | Zoryve |
| Abbott Laboratories | $36.16 | 2025 | Freestyle Libre 3 |
| Aytu Biopharma, INC. | $32.45 | 2019 | |
| Janssen Biotech, INC. | $29.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.69 | 2020 | |
| Astellas Pharma US INC | $19.09 | 2024 | Izervay |
| Sunovion Pharmaceuticals INC. | $18.95 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.59 | 2023 | Rexulti |
| Seqirus USA INC | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Luu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.